RRML - What about microparticles? Perspectives and practical aspects

ISSN online: 2284-5623

ISSN-L: 1841-6624

Impact factor (2020): 1.027

Rejection rate (2020): 75%

Română English

Clarivate analytics (ISI) Impact factor

Advanced search

Top 10 downloaded articles
- October 2021 -
Atellica CH 930 chemistry anal... 13
Cell Cycle Regulatory CCND1 G8... 11
Circulating amino acids as fin... 8
Romanian Review of Laboratory ... 7
COVID-19 associated coagulopat... 7
Insights into Innate Immune Re... 6
VEGF-C and podoplanin, as biom... 6
Agreement between two diagnost... 6
Evaluation of the impact of Co... 6
Mutations in the KRAS gene as ... 6

Log in

Concept, Design & Programming
Dr. Adrian Man

Nr. 21(1)/2013 DOI:10.2478/rrlm-2013-0013

What about microparticles? Perspectives and practical aspects

Andra Costache, Simona I. Avram, Alina Cernucan, Doina Barbu, Silvana Angelescu, Delia Mut Popescu, Anca R. Lupu


The first description of microparticles dates back to 1967, when Wolf reported platelet membrane fragments in human plasma and called them “platelet dust”. These vesicles were later called microparticles and the knowledge about their characterization and function has advanced since then. The generation of microparticles represents a mechanism of intercellular communication, playing various roles in both physiological and pathological conditions. Besides other multiple roles in pathology such as inflammation, atherogenesis and cancer spreading, platelet-derived microparticles are involved in thrombogenesis. Tissue factor and phosphatidylserine are both exposed on the outer membrane of platelet-derived microparticles, providing catalytic procoagulant surfaces. The evaluation of microparticles may represent a possible investigation and diagnostic tool. Their enumeration and characterization is challenging and flow cytometry remains the most widely used method for the analysis of microparticles. The aim of the authors is to review the most relevant information on the main properties, mechanisms of generation, and clinical relevance of platelet-derived microparticles, since their evaluation is increasingly considered as a diagnostic biomarker.

Keywords: microparticles,haemostasis,flow cytometry

  PDF Download full text PDF
(228 KB)
How to cite
Costache A, Avram SI, Cernucan A, Barbu D, Angelescu S, Mut Popescu D, et al. What about microparticles? Perspectives and practical aspects. Rev Romana Med Lab. 2013;21(1):9-15. DOI:10.2478/rrlm-2013-0013